2026-03-06
15:14 |
|
10 p, 1.1 MB |
Clozapine use and COVID-19 risk : A systematic review, meta-analysis, and retrospective cohort evidence
/
Sagués, Teresa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ferrer, Alex (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Delgado, Juan Francisco (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Julia Agullo, German (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Rodríguez-González, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ruiz, Àngels (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Estrada, Francesc (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Soria, Virgina (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Palao, Diego (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Labad, Javier (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Montalvo Aguirrezabala, Itziar (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Background: Clozapine's immune-modulating effects, including neutropenia and suppression of adaptive immunity, have raised concerns about its potential impact on SARS-CoV-2 infection risk and COVID-19 severity in individuals with treatment-resistant schizophrenia. [...]
2026 -  10.1016/j.psychres.2026.117040
Psychiatry research, Vol. 359 (February 2026) , art. 117040
|
|
2026-03-05
16:16 |
|
2026-03-04
19:12 |
|
11 p, 959.8 KB |
Characterization of thrombosis risk in ambulatory patients with cancer : Results of the observational, prospective, multicenter CARTAGO study
/
Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ;
García-Escobar, Ignacio (Universidad de Toledo) ;
Salgado, Mercedes (Complejo Hospitalario Universitario de Ourense (Galícia)) ;
Araújo, António (University of Porto) ;
Martínez de Castro, Eva (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Molina, Raquel (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Castellón-Rubio, Victoria E. (Complejo Hospitalario Torrecárdenas (Almeria)) ;
Domènech, Pere (Hospital Universitari de Bellvitge) ;
Gallardo Díaz, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Colomé, Esteve (Medical Affairs Department, LEO Pharma) ;
Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública) ;
Benítez Montañez, José Carlos (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Porta, Rut (Institut Català d'Oncologia (Barcelona)) ;
Lobo-De-Mena, Míriam (Hospital General Universitario de Valencia) ;
Malheiro, Mariana (São Francisco Xavier Hospital) ;
Font, C. (Hospital Clínic i Provincial de Barcelona) ;
Brozos-Vázquez, Elena (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Garicano, Fernando (Hospital de Galdakao (Usansolo, Biscaia)) ;
Sapena, Victor (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública) ;
Costa, Ana-Lucia (Santa Maria Hospital, Lisboa Norte Hospital Centre (CHLN)) ;
Albuquerque, Ana Cristina (Setúbal Hospital Centre) ;
Cerezuela, Pablo (Hospital Universitario Virgen de la Arrixaca (Múrcia))
Background: Venous thromboembolism (VTE) is one of the leading causes of death in patients with cancer. Currently, there is a need to develop an easily applicable risk model that can identify patients who will benefit from receiving primary thromboprophylaxis to reduce the incidence of VTE. [...]
2024 - 10.1093/oncolo/oyae334
The Oncologist, Vol. 30, Num. 8 (December 2024) , art. oyae334
|
|
2026-03-05
08:14 |
|
14 p, 9.7 MB |
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases
/
Tombal, Bertrand (Université Catholique de Louvain) ;
Saad, Fred (Université de Montréal) ;
Gallardo Díaz, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Soares, Andrey (Albert Einstein Hospital (Brasil)) ;
Loriot, Yohann (Université Paris-Saclay) ;
McDermott, Ray (Tallaght University Hospital (Dublin, Irlanda)) ;
Briers, Erik (Europa Uomo (Antwerp, Bèlgica)) ;
Lagström, Mikael (Åland (Finlàndia)) ;
Coens, Corneel (European Organisation of Research and Treatment of Cancer (Brussels, Bèlgica)) ;
Poncet, Coralie (European Organisation of Research and Treatment of Cancer (Brussels, Bèlgica)) ;
Fournier, Beatrice (European Organisation of Research and Treatment of Cancer (Brussels, Bèlgica)) ;
Gillessen, Silke (Università della Svizzera Italiana (Lugano, Suïssa)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
What is this summary about? Enzalutamide and radium-223 are two different types of medicines normally used separately to treat prostate cancer that has spread to other parts of the body (metastatic castration-resistant prostate cancer; mCRPC). [...]
2025 - 10.1080/14796694.2025.2592722
Future oncology (London, England), Vol. 21 (November 2025) , p. 3845-3858
|
|
2026-02-26
10:35 |
|
18 p, 1.2 MB |
Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol : A United Kingdom General Practice Cohort Study
/
Woodcock, Ashley (Manchester Academic Health Sciences Centre) ;
Blakey, John (Curtin University. Medical School) ;
Bourdin, Arnaud (University of Montpellier. Department of Respiratory Diseases) ;
Canonica, G. Walter (Humanitas University. Department of Biomedical Sciences) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ford, Alexander (Adelphi Real World) ;
Hulme, Rosie (Adelphi Real World) ;
Tritton, Theo (Adelphi Real World) ;
Palomares, Ines (GSK. RWE & Health Outcomes Research, Global Health) ;
Sadhu, Sanchayita (GSK. Biostatistics) ;
Biswas, Arunangshu (GSK. Biostatistics) ;
Verma, Manish (GSK. Global Medical Affairs, General Medicine)
Introduction: It is important that treatment recommendations reflect real-world data when available, as randomised controlled trials have stringent eligibility criteria and do not represent the entire asthma population or their usual ecosystem of care. [...]
2025 - 10.1007/s41030-025-00313-2
Pulmonary Therapy, Vol. 11, Num. 4 (December 2025) , p. 705-722
|
|
2026-02-27
21:14 |
|
18 p, 1.1 MB |
Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/Formoterol Fumarate in General Practice in England
/
Woodcock, Ashley (Manchester Academic Health Sciences Centre) ;
Blakey, John (Curtin University. Medical School) ;
Bourdin, Arnaud (University of Montpellier. Department of Respiratory Diseases) ;
Canonica, G. Walter (Humanitas University. Department of Biomedical Sciences) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ford, Alexander (Adelphi Real World) ;
Hulme, Rosie (Adelphi Real World) ;
Tritton, Theo (Adelphi Real World) ;
Palomares, Ines (GSK. RWE & Health Outcomes Research, Global Health) ;
Sadhu, Sanchayita (GSK. Biostatistics) ;
Biswas, Arunangshu (GSK. Biostatistics) ;
Verma, Manish (GSK. Global Medical Affairs, General Medicine)
Introduction: We compared the real-world effectiveness of initiating beclometasone dipro- pionate/formoterol fumarate (BDP/FOR) versus fluticasone furoate/vilanterol (FF/VI) in a general practice (GP) asthma cohort in England. [...]
2025 - 10.1007/s12325-025-03349-7
Advances in Therapy, Vol. 42 (September 2025) , p. 5960-5977
|
|
2026-03-05
08:14 |
|
12 p, 1.3 MB |
Suicidal ideation with and without intention to act : A transdiagnostic network analysis on the interplay between psychopathology, impulsivity, and childhood maltreatment
/
De Prisco, Michele (Hospital Clínic i Provincial de Barcelona) ;
Roberto, Natalia (Hospital Clínic i Provincial de Barcelona) ;
Andreo-Jover, Jorge (Hospital Universitario La Paz (Madrid)) ;
Ayad-Ahmed, Wala (Universidad Complutense de Madrid) ;
Bobes-Bascarán, Maria T. (Universidad de Oviedo) ;
Canal-Rivero, Manuel (Universidad de Sevilla) ;
Canosa García, Irene (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Cebrià, Annabel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Crespo-Facorro, Benedicto (Universidad de Sevilla) ;
Curto-Ramos, Javier (Hospital Universitario La Paz (Madrid)) ;
Diaz-Marsa, Marina (Universidad Complutense de Madrid) ;
de la Torre-Luque, Alejandro (Universidad Complutense de Madrid) ;
Elices, M. (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Jiménez-Treviño, Luis (Universidad de Oviedo) ;
Palao-Tarrero, Angela (Universidad Autónoma de Madrid) ;
Palao, Diego (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Pemau, Andrés (Universidad Complutense de Madrid) ;
Lopez-Pena, Maria Purificacion (Hospital Universitario de Alava (Vitòria, País Basc)) ;
Ruiz Veguilla, Miguel (Hospital del Mar (Barcelona, Catalunya)) ;
Sáiz, Pilar Alejandra (Universidad de Oviedo) ;
Suárez-Soto, Elizabeth (Universitat de Barcelona) ;
Courtet, Philippe (University of Montpellier (França)) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Grande, Iria (Hospital Clínic i Provincial de Barcelona) ;
Pérez Solà, Víctor (Institut Hospital del Mar d'Investigacions Mèdiques)
Suicide represents a significant public health concern. Suicide prevention strategies are shifting toward transdiagnostic perspectives examining interrelated risk factors, but their interrelationships remain unclear. [...]
2025 - 10.1017/S0033291725101670
Psychological Medicine, Vol. 55 (October 2025) , art. e312
|
|
2026-02-26
14:12 |
|
10 p, 398.6 KB |
Prevalence and consequences of patient-ventilator interactions in a cohort of home-ventilated restrictive and neuromuscular patients : a multicentre study
/
Lalmolda, Cristina (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Pomares, Xavier (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Martí, Sergi (Hospital Universitari Vall d'Hebron) ;
Ferré Masó, Alex (Hospital Universitari Vall d'Hebron) ;
Farrero, Eva (Hospital Universitari de Bellvitge) ;
Prats, Enric (Hospital Universitari de Bellvitge) ;
Flórez, Pablo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Magrans, Rudys (Better Care (Catalunya)) ;
Montanyà, Jaume (Better Care (Catalunya)) ;
Montón, Concepción (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Luján, Manel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Analysis of patient-ventilator interactions in patients on chronic home mechanical ventilation can be time consuming, and the consequences of individual interaction on pulmonary gas exchange are not well understood. [...]
2025 - 10.1183/23120541.01388-2024
ERJ Open Research, Vol. 11 (November 2025) , art. 01388-2024
|
|
2026-02-27
21:14 |
|
2 p, 155.6 KB |
Correction to : Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England
/
Woodcock, Ashley (Manchester Academic Health Sciences Centre) ;
Blakey, John (Curtin University. Medical School) ;
Bourdin, Arnaud (University of Montpellier. Department of Respiratory Diseases) ;
Canonica, G. Walter (Humanitas University. Department of Biomedical Sciences) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ford, Alexander (Adelphi Real World) ;
Hulme, Rosie (Adelphi Real World) ;
Tritton, Theo (Adelphi Real World) ;
Palomares, Ines (GSK. RWE & Health Outcomes Research, Global Health) ;
Sadhu, Sanchayita (GSK. Biostatistics) ;
Biswas, Arunangshu (GSK. Biostatistics) ;
Verma, Manish (GSK. Global Medical Affairs, General Medicine)
2025 - 10.1007/s12325-025-03407-0
Advances in Therapy, Vol. 42 (November 2025) , p. 5978-5979
|
|
2026-02-27
21:14 |
|
2 p, 154.9 KB |
Correction : Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol: A United Kingdom General Practice Cohort Study
/
Woodcock, Ashley (Manchester Academic Health Sciences Centre) ;
Blakey, John (Curtin University. Medical School) ;
Bourdin, Arnaud (University of Montpellier. Department of Respiratory Diseases) ;
Canonica, G. Walter (Humanitas University. Department of Biomedical Sciences) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ford, Alexander (Adelphi Real World) ;
Hulme, Rosie (Adelphi Real World) ;
Tritton, Theo (Adelphi Real World) ;
Palomares, Ines (GSK. RWE & Health Outcomes Research, Global Health) ;
Sadhu, Sanchayita (GSK. Biostatistics) ;
Biswas, Arunangshu (GSK. Biostatistics) ;
Verma, Manish (GSK. Global Medical Affairs, General Medicine)
2025 - 10.1007/s41030-025-00325-y
Pulmonary Therapy, Vol. 11 (October 2025) , p. 723-724
|
|
|
|
visitant ::
identificació
Estadístiques d'ús
Els més consultats
